Kreuzer Martin, Prüfe Jenny, Oldhafer Martina, Bethe Dirk, Dierks Marie-Luise, Müther Silvia, Thumfart Julia, Hoppe Bernd, Büscher Anja, Rascher Wolfgang, Hansen Matthias, Pohl Martin, Kemper Markus J, Drube Jens, Rieger Susanne, John Ulrike, Taylan Christina, Dittrich Katalin, Hollenbach Sabine, Klaus Günter, Fehrenbach Henry, Kranz Birgitta, Montoya Carmen, Lange-Sperandio Bärbel, Ruckenbrodt Bettina, Billing Heiko, Staude Hagen, Heindl-Rusai Krisztina, Brunkhorst Reinhard, Pape Lars
From the Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School (MK, JP, JD, LP); German Society of Transition Medicine, Hannover (MK, MO, SM, LP); Division of Pediatric Nephrology, Center for Child and Adolescent Medicine, Heidelberg University Hospital, Heidelberg (DB, SR); Department of Epidemiology, Social Medicine and Health System Research, Hannover Medical School, Hannover (M-LD); Berliner Transitions Programm (BTP), DRK-Kliniken (German Red Cross hospitals) Berlin Westend (SM); Department of Pediatric Nephrology, Charité, Berlin (JT); University Hospital of Bonn, Bonn (BH); Department of Pediatrics II, Essen University Hospital, Essen (AB); Childrens' Hospital, University of Erlangen, Erlangen (WR); KfH Center of Pediatric Nephrology, Clementine Childrens' Hospital, Frankfurt (MH); Department of General Pediatrics, Adolescent Medicine and Neonatology, Freiburg University Hospital, Freiburg (MP); University Childrens' Hospital Eppendorf, Hamburg (MJK); University Childrens' Hospital, Jena (UJ); Pediatric Nephrology, University Hospital of Cologne, Cologne (CT); University Childrens' Hospital (KD); KfH Center of Pediatric Nephrology, St. Georg Hospital, Leipzig (SH); KfH Center of Pediatric Nephrology, University Hospital of Marburg, Marburg (GK); KfH Center of Pediatric Nephrology, Childrens' Hospital Memmingen, Memmingen (HF); University Childrens' Hospital Münster (BK); KfH Center of Pediatric Nephrology, University Childrens' Hospital München Schwabing (CM); Dr. von Haunersches Kinderspital, Ludwigs Maximilian University, Munich (BL-S); Childrens' Hospital, Olgahospital Klinikum Stuttgart, Stuttgart (BR); University Childrens' Hospital Tübingen, Tübingen (HB); University Childrens' Hospital, Rostock, Germany (HS); University Childrens' Hospital, Vienna, Austria (KH-R); and KfH Center of Nephrology, Hospitals of the Hannover Region, Hannover, Germany (RB).
Medicine (Baltimore). 2015 Dec;94(48):e2196. doi: 10.1097/MD.0000000000002196.
Transition from child to adult-oriented care is widely regarded a challenging period for young people with kidney transplants and is associated with a high risk of graft failure. We analyzed the existing transition structures in Germany and Austria using a questionnaire and retrospective data of 119 patients transferred in 2011 to 2012. Most centers (73%) confirmed agreements on the transition procedure. Patients' age at transfer was subject to regulation in 73% (18 years). Median age at transition was 18.3 years (16.5-36.7). Median serum creatinine increased from 123 to 132 μmol/L over the 12 month observation period before transfer (P = 0.002). A total of 25/119 patients showed increased creatinine ≥ 20% just before transfer. Biopsy proven rejection was found in 10/119 patients. Three patients lost their graft due to chronic graft nephropathy.Mean coefficient of variation (CoV%) of immunosuppression levels was 0.20 ± 0.1. Increased creatinine levels ≥ 20% just before transfer were less frequently seen in patients with CoV < 0.20 (P = 0.007). The majority of pediatric nephrology centers have internal agreements on transitional care. More than half of the patients had CoV of immunosuppression trough levels consistent with good adherence. Although, 20% of the patients showed increase in serum creatinine close to transfer.
从儿童护理向成人护理的过渡被广泛认为是肾移植青少年面临的一个具有挑战性的时期,并且与移植失败的高风险相关。我们使用问卷调查和2011年至2012年转诊的119例患者的回顾性数据,分析了德国和奥地利现有的过渡结构。大多数中心(73%)确认了关于过渡程序的协议。73%(18岁)的中心对转诊时患者的年龄有规定。过渡时的中位年龄为18.3岁(16.5 - 36.7岁)。在转诊前12个月的观察期内,血清肌酐中位数从123 μmol/L升至132 μmol/L(P = 0.002)。在119例患者中,共有25例在转诊前肌酐升高≥20%。119例患者中发现10例经活检证实有排斥反应。3例患者因慢性移植肾病失去了移植肾。免疫抑制水平的平均变异系数(CoV%)为0.20±0.1。CoV<0.20的患者在转诊前肌酐水平升高≥20%的情况较少见(P = 0.007)。大多数儿科肾脏病中心在过渡护理方面有内部协议。超过一半的患者免疫抑制谷值水平的CoV与良好的依从性一致。尽管如此,20%的患者在转诊临近时血清肌酐升高。